Literature DB >> 35677503

The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease.

Qian Li1,2, Julia D Rempel1,2, Jiaqi Yang1, Gerald Y Minuk1,3.   

Abstract

Background: Innate immune responses to gut-derived pathogen-associated molecular patterns (PAMPs) have been implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Whether NAFLD patients have increased sensitivity to PAMP exposure has yet to be reported.
Methods: Peripheral blood mononuclear cell (PBMC)/monocytes were exposed to lipopolysaccharide (LPS), Pam3CSK4, or BSA conjugated palmitate in vitro. Changes in toll-like receptors (TLR), cytokines, and chemokine receptors (CR) expressions were documented by flow cytometry and/or enzyme-linked immunoabsorbent assays (ELISAs).
Results: TLR2 and TLR4 expression were similar at baseline and increased to a similar extent (TLR2) or remained unchanged (TLR4) following PAMP exposure in NAFLD and healthy control (HC) monocytes. Proinflammatory IL-1β and IL-6 levels were similar at baseline but increased in a concentration-dependent manner to a greater extent in NAFLD PBMCs. CCR1 and CCR2 expressions at baseline were similar and decreased to a similar extent in NAFLD and HC monocytes. The extent of PAMP-induced proinflammatory cytokine release correlated with evidence of hepatocyte injury (CK18M30 levels). Discussion: NAFLD patients have increased proinflammatory cytokine responses following exposure to PAMPs relative to HC subjects. This response is concentration-dependent and correlates with the extent of hepatic injury.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALT, alanine aminotransferase; CM, culture medium; CR, chemokine receptor; ELISAs, enzyme-linked immunoabsorbent assays; HC, healthy controls; LPS, lipopolysaccharide; NAFLD; NAFLD, nonalcoholic fatty liver disease; NASH; PAMPs; PAMPs, pathogen-associated molecular patterns; PBMC, peripheral blood mononuclear cell; Pal, palmitate; Pam, Pam3CSK4; TLR, toll-like receptor; nonalcoholic fatty liver disease; pathogen-associated molecular patterns

Year:  2021        PMID: 35677503      PMCID: PMC9168738          DOI: 10.1016/j.jceh.2021.11.011

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  30 in total

1.  Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms.

Authors:  Koko Bate Aborsangaya; Iga Dembinski; Suresh Khatkar; Martin Prince Alphonse; Peter Nickerson; Julia D Rempel
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

Review 2.  Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.

Authors:  Anna M Diehl; Christopher Day
Journal:  N Engl J Med       Date:  2017-11-23       Impact factor: 91.245

3.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Paola Brun; Ignazio Castagliuolo; Vincenza Di Leo; Andrea Buda; Massimo Pinzani; Giorgio Palù; Diego Martines
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-05       Impact factor: 4.052

4.  Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

Authors:  Anna Alisi; Melania Manco; Rita Devito; Fiorella Piemonte; Valerio Nobili
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-06       Impact factor: 2.839

Review 5.  Treatment of NAFLD with diet, physical activity and exercise.

Authors:  Manuel Romero-Gómez; Shira Zelber-Sagi; Michael Trenell
Journal:  J Hepatol       Date:  2017-05-23       Impact factor: 25.083

6.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

Authors:  Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

7.  Chronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte Subsets.

Authors:  Rafael T Mattos; Nayara I Medeiros; Carlos A Menezes; Rafaelle C G Fares; Eliza P Franco; Walderez O Dutra; Fabrício Rios-Santos; Rodrigo Correa-Oliveira; Juliana A S Gomes
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

8.  Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin.

Authors:  Yuji Ogawa; Kento Imajo; Yasushi Honda; Takaomi Kessoku; Wataru Tomeno; Shingo Kato; Koji Fujita; Masato Yoneda; Satoru Saito; Yusuke Saigusa; Hideyuki Hyogo; Yoshio Sumida; Yoshito Itoh; Kosei Eguchi; Takeharu Yamanaka; Koichiro Wada; Atsushi Nakajima
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

9.  Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation.

Authors:  Rasheed Ahmad; Anfal Al-Mass; Valerie Atizado; Asma Al-Hubail; Fahad Al-Ghimlas; Monira Al-Arouj; Abdullah Bennakhi; Said Dermime; Kazem Behbehani
Journal:  J Inflamm (Lond)       Date:  2012-11-28       Impact factor: 4.981

10.  Systemic and Splanchnic Lipopolysaccharide and Endothelin-1 Plasma Levels in Liver Cirrhosis before and after Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Jiaxiang Meng; Qing Wang; Kai Liu; Shuofei Yang; Xinxin Fan; Baochen Liu; Changsheng He; Xingjiang Wu
Journal:  Gastroenterol Res Pract       Date:  2016-01-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.